Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library-Reference-Cited by-同舟云学术

Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library

Published:2021-06 Issue:6 Volume:112 Page:2454-2466
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yagishita Shigehiro¹^ORCID,Kato Ken²³,Takahashi Mami⁴^ORCID,Imai Toshio⁴^ORCID,Yatabe Yasushi⁵^ORCID,Kuwata Takeshi⁶,Suzuki Mikiko¹,Ochiai Atsushi⁷^ORCID,Ohtsu Atsushi⁸,Shimada Kazuaki⁹¹⁰,Nishida Toshirou¹⁰¹¹,Hamada Akinobu¹,Mano Hiroyuki¹²^ORCID

Affiliation:

1. Division of Molecular Pharmacology National Cancer Center Research Institute Chuo‐ku Japan

2. Department of Head and Neck Medical Oncology National Cancer Center Hospital Chuo‐ku Japan

3. Biobank Translational Research Support Section Clinical Research Support Office National Cancer Center Hospital Chuo‐ku Japan

4. Central Animal Division National Cancer Center Research Institute Chuo‐ku Japan

5. Department of Diagnostic Pathology National Cancer Center Hospital Chuo‐ku Japan

6. Department of Genetic Medicine and Services National Cancer Center Hospital East Kashiwa‐shi Japan

7. Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa‐shi Japan

8. National Cancer Center Hospital East Kashiwa‐shi Japan

9. Department of Gastric Surgery National Cancer Center Hospital Chuo‐ku Japan

10. National Cancer Center Hospital Chuo‐ku Japan

11. Department of Surgery Japan Community Health care Organization Osaka Hospital Osaka Japan

12. National Cancer Center Research Institute Chuo‐ku Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14899

Reference33 articles.

1. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

2. Examining the utility of patient-derived xenograft mouse models

3. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

4. How to improve R&D productivity: the pharmaceutical industry's grand challenge

5. Parsing clinical success rates;Mullard A;Nat Rev Drug Discov,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations;Molecular Cancer;2024-06-11

2. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency;npj Precision Oncology;2024-05-24

3. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges;BMC Cancer;2023-12-07

4. Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma;Gynecologic Oncology Reports;2023-12

5. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals;Cancer Genomics - Proteomics;2023-11-30